Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wen-Hui Weng

Showing results (41-50 of 46) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 46 results.
Hepatology (Baltimore, Md.)|January 20, 2011
Neuregulin/erythroblastic leukemia viral oncogene homolog 3 autocrine loop contributes to invasion and early recurrence of human hepatomaSen-Yung Hsieh, Jung-Ru He, Chih-Yun Hsu, et al.
Experimental and Therapeutic Medicine|September 29, 2021
Gain of TPPP as a predictor of progression in patients with bladder cancerYing-Hsu Chang, Po-Hung Lin, Chin-Chang Chen, et al.
Annals of Surgical Oncology|June 8, 2023
Should Patients with Renal Cell Carcinoma and Pathological Nodal Invasion Be Classified As Having Stage IV Disease?Kai-Jie Yu, Sy-Yuan Chen, Po-Hung Lin, et al.
Genome Medicine|May 28, 2015
Mutation signatures implicate aristolochic acid in bladder cancer developmentSong Ling Poon, Mi Ni Huang, Yang Choo, et al.
Science Translational Medicine|February 24, 2017
Loss of tumor suppressor KDM6A amplifies PRC2-regulated transcriptional repression in bladder cancer and can be targeted through inhibition of EZH2Lian Dee Ler, Sujoy Ghosh, Xiaoran Chai, et al.
Science Translational Medicine|August 9, 2013
Genome-wide mutational signatures of aristolochic acid and its application as a screening toolSong Ling Poon, See-Tong Pang, John R McPherson, et al.
Pageof 5

Showing results (41-50 of 46) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 46 results.
Hepatology (Baltimore, Md.)|January 20, 2011
Neuregulin/erythroblastic leukemia viral oncogene homolog 3 autocrine loop contributes to invasion and early recurrence of human hepatomaSen-Yung Hsieh, Jung-Ru He, Chih-Yun Hsu, et al.
Experimental and Therapeutic Medicine|September 29, 2021
Gain of TPPP as a predictor of progression in patients with bladder cancerYing-Hsu Chang, Po-Hung Lin, Chin-Chang Chen, et al.
Annals of Surgical Oncology|June 8, 2023
Should Patients with Renal Cell Carcinoma and Pathological Nodal Invasion Be Classified As Having Stage IV Disease?Kai-Jie Yu, Sy-Yuan Chen, Po-Hung Lin, et al.
Genome Medicine|May 28, 2015
Mutation signatures implicate aristolochic acid in bladder cancer developmentSong Ling Poon, Mi Ni Huang, Yang Choo, et al.
Science Translational Medicine|February 24, 2017
Loss of tumor suppressor KDM6A amplifies PRC2-regulated transcriptional repression in bladder cancer and can be targeted through inhibition of EZH2Lian Dee Ler, Sujoy Ghosh, Xiaoran Chai, et al.
Science Translational Medicine|August 9, 2013
Genome-wide mutational signatures of aristolochic acid and its application as a screening toolSong Ling Poon, See-Tong Pang, John R McPherson, et al.
Pageof 5